Navigation Links
New England Patriots Offensive Line Wins Second Annual Madden Most Valuable Protectors Award Presented by Prilosec OTC®
Date:2/3/2011

ge and to see how two of the league's toughest offensive linemen – Giants' David Diehl and Vikings' Anthony Herrera – protected themselves this season against heartburn.

All player participation will be facilitated by NFL PLAYERS, the licensing and marketing subsidiary of the NFL Players Association.  Prilosec OTC is the Official Heartburn Remedy Sponsor of the NFL.

About PRILOSEC OTC

PRILOSEC OTC® is the #1 physician recommended OTC acid reducer(3) in the U.S. for the period of April 2009 through March 2010, the #1 Pharmacist recommended OTC Heartburn medicine(4) and the first of a class of OTC heartburn medicines that treats frequent heartburn with just one pill a day. Prilosec OTC® is a leading frequent heartburn medicine that can work for 24 hours with one pill a day by directly shutting down many acid pumps in your stomach when used as directed for 14 days for treating frequent heartburn. For more information about PRILOSEC OTC®, visit www.prilosecotc.com. PRILOSEC OTC® is available over-the-counter through an alliance between P&G and AstraZeneca.

About Procter and Gamble

Four billion times a day, P&G brands touch the lives of people around the world. The company has one of the strongest portfolios of trusted, quality, leadership brands, including Pampers®, Tide®, Ariel®, Always®, Whisper®, Pantene®, Mach3®, Bounty®, Dawn®, Gain®, Pringles®, Charmin®, Downy®, Lenor®, Iams®, Crest®, Oral-B®, Duracell®, Olay®, Head & Shoulders®, Wella®, Gillette®, Braun® and Fusion®. The P&G community includes approximately 135,000 employees working in about 80 countries worldw
'/>"/>

SOURCE Procter and Gamble
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pescatello Elected to Head New England Biotech Association in 2011-12
2. Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine
3. Study Published in New England Journal of Medicine Shows Nplate® Significantly Reduces Treatment Failure and Splenectomy Rate in Patients With Chronic ITP
4. Results From an Expanded Cohort Phase 1 Study Published in the New England Journal of Medicine Demonstrate a Majority of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Crizotinib (PF-02341066)
5. New England Biolabs Launches a Suite of Innovative Tools to Advance Epigenetics Research, Including PCR-Based Assay to Identify and Quantitate 5-hmC in Epigenome
6. New England Biolabs Receives Award to Develop Novel Enzymatic Reagents for Epigenetic Studies
7. ViroPharma Announces Publication of Cinryze™ (C1 Esterase Inhibitor [Human]) Phase 3 Trial Results in Hereditary Angioedema (HAE) in the New England Journal of Medicine
8. New England Biolabs Launches NEBNext™ Quick DNA Sample Prep Reagent Sets for Use With Roche/454 Next Generation Sequencing Platforms
9. The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbotts Carotid Stent System and Surgery
10. Whistleblower Lawyers Comment on New England Journal of Medicine Study
11. STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... and SAN DIEGO , Dec. 17, ... PHG ; AEX: PHIA) and Volcano Corporation (NASDAQ: ... solutions for cardiovascular applications, today announced that they have entered ... will commence a tender offer to acquire all of the ... share, or a total equity purchase price of USD 1 ...
(Date:12/17/2014)... 17, 2014  Northstar Global Business Services, Inc. ... (DTC) has made their final decision and has ... Company,s stock effective December 15, 2014, and has ... depository and book entry transfer services. All deposit restrictions ... once again fully "DTC Eligible", and has resumed ...
(Date:12/17/2014)... , Dec. 17, 2014  ImmunoCellular Therapeutics, Ltd. ... Patent and Trademark Office (USPTO) has issued a ... dendritic cell-based immunotherapeutic vaccine targeting six tumor antigens ... of US Patent No. 8,871,211, which issued October ... by administering a dendritic cell composition comprising peptide ...
Breaking Medicine Technology:Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2
... ... research and biotechnology companies are testing 97 medicines and vaccines to ... report released today by the Pharmaceutical Research and Manufacturers of America ... - a global awareness campaign that originated at the 1988 World ...
... , XI,AN, China, Nov. ... a leading developer and producer,of plant extracts and pharmaceutical raw ... China, today reported that in its,third quarter, the company realized ... Revenues for the quarter ended Sept. 30, 2009 were $4,465,770, ...
Cached Medicine Technology:New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 3Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 2Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 3Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 4
(Date:12/22/2014)... 2014 The NLN’s 2015 ... programs this month. Faculty have been selected through ... educators fast-tracked for administrative leadership roles within their ... for Simulation Educators, featuring a curriculum uniquely devised ... education. , Twenty nurse educators were chosen ...
(Date:12/21/2014)... In this report, the global powered surgical instruments ... application. The market, by power source, is segmented ... the market covers the handpieces; power source and ... further subdivided into drills, saws, reamers, staplers, vessel ... drivers, and others. Moreover, the power source and ...
(Date:12/21/2014)... December 22, 2014 BellasDress.com offers a ... for women. Today, it announces its BellasDress Christmas ... at its online store. , BellasDress is a famous ... to its fans through a series of promotions. The ... every customer. , “We are proud of offering ...
(Date:12/21/2014)... 21, 2014 AngelWeddingDress.com’s new collection of ... a total of 1,000 new designs in this collection, ... spring 2015. , AngelWeddingDress.com promises to provide ... with wardrobe essentials while many fashion trends come and ... customer service team at AngelWeddingDress.com is ready to assist. ...
(Date:12/21/2014)... Recently, one of the best prom dresses online ... has introduced its new collection of 2015 prom dresses, ... all its prom dresses & other fashionable designs, up ... top quality dress products and great customer services to ... of the best prom dresses online shops around the ...
Breaking Medicine News(10 mins):Health News:NLN Leadership Institute Announces 2015 Cohorts 2Health News:NLN Leadership Institute Announces 2015 Cohorts 3Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 3Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 4Health News:BellasDress.com Announces its BellasDress Christmas Sale 2Health News:2015 Spring Wedding Dresses From AngelWeddingDress Just Released 2Health News:New Prom Dresses From One Of The Best Prom Dresses Online Shops, LunaDress Prom Shop 2
... Increase Access, Lower Drug Costs for America,s Seniors, ... released by,the Office of Inspector General (OIG) finding ... 88 percent of the time when generic,substitutes were ... dispensed are,generics confirms that proven pharmacy benefit manager ...
... Patient Privacy,Protections, LOS ANGELES, Nov. 16 ... Association (AMA) for,recently updating its HIV testing policy ... protection of patient privacy. According,to a news item ... the,AMA,s new guidelines call for, "...physicians to routinely ...
... ZYRTEC-D(R) 12 HOUR(R) to be Available in Stores Nationwide ... ... Nov. 16 McNeil Consumer,Healthcare, a division of McNEIL-PPC, Inc., announced ... (FDA) for the,allergy treatment ZYRTEC(R) (cetirizine HCl) to be used without ...
... Nov. 16 House Republican Whip,Roy Blunt (Mo.) ... "compromise" offer to reduce their spending demands from,$22 ... offered to ,compromise, and reduce their demand,for increased ... this offer did not include anything about which ...
... LAUDERDALE, Fla., Nov. 16 The National Football,League ... program,focusing on heart health screenings for former NFL ... Broward General Medical Center.,Partnering with Dr. Jeffrey Boone, ... General provided medical experts and a 64-slice CT ...
... Home Health,announced today that it has completed the ... agencies in Florida. HHCA also has seven,agencies in ... and continue,to operate. HHCA is a large ... HHCA has specialty skilled nursing programs,in cardiac, diabetic, ...
Cached Medicine News:Health News:New OIG Report Confirms Part D Plans Are Driving Generic Utilization 2Health News:AMA's New HIV Testing Guidelines Good for Public Health, Says AHF 2Health News:FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription 2Health News:FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription 3Health News:FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription 4Health News:Broward Health and ProHeart MD Kick Off NFL Alumni Health Program 2Health News:AseraCare Home Health Expands Through Acquisition of 11 Home Health Corporation of America Agencies 2
... CardioSEAL is a second generation device, ... was tested in over 700 patients beginning ... of leading pediatric cardiologists who perform these ... computer simulations, on the engineering bench, and ...
... YAG laser YC-1600 is a lightweight, compact, ... and clinical performance., ,Key Features, , ... Model ,Further weight reduction has been made ... office.,, Aiming Beam Rotation ,(360 degrees ...
... delivers a solid-state green laser ... and plugs into any standard ... and extreme portability, the unit ... Nidek Phaco Emulsification System CV-24000 ...
... is an effective angina relief ... poor targets. Because it is ... the CO2 Heart Laser 2 ... timely operative decisions to revascularize ...
Medicine Products: